Buprenorphine Available at 39.4 Percent of U.S. Pharmacies in 2023
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Sept. 3, 2025 -- From 2017 to 2023, there was an increase in buprenorphine availability overall, reaching 39.4 percent in 2023, according to a study published online Sept. 2 in Health Affairs.
Jenny S. Guadamuz, Ph.D., from the University of California Berkeley, and colleagues examined trends in the availability of buprenorphine at U.S. retail pharmacies in 2017 to 2023. Pharmacies with buprenorphine availability were defined as those that dispensed at least one prescription of buprenorphine each month in a given year.
The researchers found an increase in the availability of buprenorphine from 33.1 percent of pharmacies in 2017 to 39.4 percent of pharmacies in 2023. Increases were seen across all neighborhood types; pharmacies located in Black and Latinx neighborhoods were less likely to dispense buprenorphine than those serving White or diverse neighborhoods (17.8 and 16.5 percent, respectively, versus 45.8 and 30.9 percent, respectively, in 2023). Buprenorphine availability increased in most states, but declined significantly in Washington, D.C., and in five states between 2017 and 2023. In nearly all states, availability was lowest in Black and Latinx neighborhoods.
"If policymakers fail to introduce policies that increase equitable access to buprenorphine at local pharmacies, existing racial and ethnic disparities in opioid use disorder treatment and recovery will likely worsen," Guadamuz said in a statement.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.
Posted September 2025
Read this next
59.0 Percent of Overdose Deaths Involved Stimulants in 2021 to 2024
TUESDAY, Sept. 2, 2025 -- From 2021 to 2024, 59.0 percent of overdose deaths involved stimulants, according to research published in the Aug. 28 issue of the U.S. Centers for...
AAP Offers Guidance for Tapering of Opioids to Prevent Withdrawal in Children
TUESDAY, Aug. 19, 2025 -- A plan for tapering opioids should be developed to minimize withdrawal symptoms in children receiving opioids for five or more days, according to a...
Stigma of Substance Use Disorder Varies by Condition, Provider
WEDNESDAY, July 30, 2025 -- Health care provider stigma toward substance use disorder (SUD) varies by condition and provider, according to a study published online July 23 in...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.